Biju Parekkadan

Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1.

Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.

Implantable microenvironments to attract hematopoietic stem/cancer cells.

Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury.

Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators.

Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells.

Microcavity substrates casted from self-assembled microsphere monolayers for spheroid cell culture.

An engineered biomarker system to monitor and modulate immune clearance of cell therapies.

Orthogonal potency analysis of mesenchymal stromal cell function during ex vivo expansion.

Long-adapter single-strand oligonucleotide probes for the massively multiplexed cloning of kilobase genome regions.

Stromalized microreactor supports murine hematopoietic progenitor enrichment.

Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction.

The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation.

Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury.

Closed loop bioreactor system for the ex vivo expansion of human T cells.

Biomanufacturing for clinically advanced cell therapies.

Convergence of Cell Pharmacology and Drug Delivery.

Computational Simulation of Adapter Length-Dependent LASSO Probe Capture Efficiency.

Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression.

Quantitative assessment of LASSO probe assembly and long-read multiplexed cloning.

Kinetics of MSC-based enzyme therapy for immunoregulation.

Real-time transfer of lentiviral particles by producer cells using an engineered coculture system.

Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs.

Non-invasive cell counting of adherent, suspended and encapsulated mammalian cells using optical density.

Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells.

Tracking leukemic T-cell transcriptional dynamics in vivo with a blood-based reporter assay.

Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells.

Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application.

Non-invasive image-based cytometry for high throughput NK cell cytolysis analysis.

Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.

Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly.

A continuous flow cell culture system for precision cell stimulation and time-resolved profiling of cell secretion.

In Vivo Activity of Genetically Modified Cells Preseeded in Rat Vascularized Composite Allografts.

Selecting a Cell Engineering Methodology During Cell Therapy Product Development.

Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation.

Massively parallel DNA target capture using long adapter single stranded oligonucleotide (LASSO) probes assembled through a novel DNA recombinase mediated methodology.

Proceedings of the ISCT scientific signature series symposium, "sdvances in cell and gene therapies for lung diseases and critical illnesses": International society for cell & gene therapies, burlington VT, US, July 16, 2021.